(19)
(11) EP 1 119 629 A2

(12)

(88) Date of publication A3:
10.08.2000

(43) Date of publication:
01.08.2001 Bulletin 2001/31

(21) Application number: 99950258.6

(22) Date of filing: 06.10.1999
(51) International Patent Classification (IPC)7C12N 15/53, C12N 9/02, C12Q 1/68, C12N 15/63, A61K 38/44, C07K 16/40
(86) International application number:
PCT/US9923/434
(87) International publication number:
WO 0020/604 (13.04.2000 Gazette 2000/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.10.1998 US 172227 P
02.12.1998 US 155202 P
10.03.1999 US 123911 P

(71) Applicant: INCYTE PHARMACEUTICALS, INC.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • LAL, Preeti
    Santa Clara, CA 95054 (US)
  • GUEGLER, Karl, J.
    Menlo Park, CA 94025 (US)
  • GORGONE, Gina, A.
    Boulder Creek, CA 95006 (US)
  • CORLEY, Neil, C.
    Mountain View, CA 94040 (US)
  • BAUGHN, Mariah, R.
    San Leandro, CA 94577 (US)
  • TANG, Y., Tom
    San Jose, CA 95118 (US)
  • HILLMAN, Jennifer, L.
    Mountain View, CA 94040 (US)
  • BANDMAN, Olga
    Mountain View, CA 94043 (US)
  • AZIMZAI, Yalda
    Hayward, CA 94545 (US)
  • AU-YOUNG, Janice
    Brisbane, CA 94005 (US)
  • YUE, Henry
    Sunnyvale, CA 94087 (US)
  • LU, Dyung, Aina, M.
    San Jose, CA 95136 (US)
  • YANG, Junming
    San Jose, CA 95129 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) OXIDOREDUCTASE MOLECULES